Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $20.7200 (-0.29%) ($20.5900 - $21.4500) on Thu. Sep. 19, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.88% (three month average) | RSI | 48 | Latest Price | $20.7200(-0.29%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | IOVA advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.44% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-9%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.44% (StdDev 2.88%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $21.06(-1.61%) | 10 Day Moving Average | $20.78(-0.29%) | 20 Day Moving Average | $20.61(0.53%) | To recent high | -20.3% | To recent low | 6.2% | Market Cap | $3.034b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |